DE69516007T2 - Verfahren zum nachweiss von antikörpern - Google Patents

Verfahren zum nachweiss von antikörpern

Info

Publication number
DE69516007T2
DE69516007T2 DE69516007T DE69516007T DE69516007T2 DE 69516007 T2 DE69516007 T2 DE 69516007T2 DE 69516007 T DE69516007 T DE 69516007T DE 69516007 T DE69516007 T DE 69516007T DE 69516007 T2 DE69516007 T2 DE 69516007T2
Authority
DE
Germany
Prior art keywords
antigen
sample
antibodies
amount
detecting antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69516007T
Other languages
English (en)
Other versions
DE69516007D1 (de
Inventor
F Ullman
S Vold
B Metha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of DE69516007D1 publication Critical patent/DE69516007D1/de
Application granted granted Critical
Publication of DE69516007T2 publication Critical patent/DE69516007T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/971—Capture of complex after antigen-antibody reaction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69516007T 1994-09-21 1995-09-20 Verfahren zum nachweiss von antikörpern Expired - Lifetime DE69516007T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/310,028 US5561049A (en) 1994-09-21 1994-09-21 Method for detecting antibodies
PCT/US1995/011665 WO1996009552A1 (en) 1994-09-21 1995-09-20 Method for detecting antibodies

Publications (2)

Publication Number Publication Date
DE69516007D1 DE69516007D1 (de) 2000-05-04
DE69516007T2 true DE69516007T2 (de) 2000-11-02

Family

ID=23200697

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69516007T Expired - Lifetime DE69516007T2 (de) 1994-09-21 1995-09-20 Verfahren zum nachweiss von antikörpern

Country Status (9)

Country Link
US (1) US5561049A (de)
EP (1) EP0782710B1 (de)
JP (1) JP3104999B2 (de)
AT (1) ATE191277T1 (de)
AU (1) AU695419B2 (de)
CA (1) CA2200683A1 (de)
DE (1) DE69516007T2 (de)
ES (1) ES2145924T3 (de)
WO (1) WO1996009552A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3479100B2 (ja) * 1993-06-02 2003-12-15 帝国臓器製薬株式会社 免疫化学的簡易半定量方法および装置
US6933366B2 (en) * 1996-12-27 2005-08-23 Tripep Ab Specificity exchangers that redirect antibodies to bacterial adhesion receptors
US6660842B1 (en) 1994-04-28 2003-12-09 Tripep Ab Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
US6040137A (en) * 1995-04-27 2000-03-21 Tripep Ab Antigen/antibody specification exchanger
US6417324B1 (en) * 2000-04-21 2002-07-09 Tripep Ab Synthetic peptides that bind to the hepatitis B virus core and e antigens
US5929049A (en) * 1997-08-08 1999-07-27 Dade Behring Marburg Gmbh Polysaccharide conjugates of biomolecules
GB9801120D0 (en) * 1998-01-21 1998-03-18 Secr Defence Detection system
AU3487499A (en) * 1998-04-08 1999-10-25 Regents Of The University Of California, The Methods and reagents for targeting organic compounds to selected cellular locations
US7045305B1 (en) 1998-04-08 2006-05-16 The Regents Of The University Of California Methods and reagents for targeting organic compounds to selected cellular locations
GB9810040D0 (en) 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
US6303325B1 (en) 1998-05-29 2001-10-16 Dade Behring Inc. Method for detecting analytes
EP1086123A1 (de) * 1998-06-09 2001-03-28 Immco Diagnostics Elisa in lösung
GB9827228D0 (en) * 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
EP1294749A2 (de) * 2000-03-09 2003-03-26 Heska Corporation Rekombinanten antigenen zur bestimmung des immun-zustandes eines tieres
EP1275003A2 (de) 2000-04-19 2003-01-15 Research Corporation Technologies, Inc Diagnostisches assay für endometriose
US20030232399A1 (en) * 2000-06-14 2003-12-18 Robertson John Forsyth Russell Cancer detection methods and reagents
US7178152B2 (en) * 2001-03-01 2007-02-13 Sony Corporation Application programming interface for communication between audio/video file system and audio video controller
WO2003016575A1 (en) * 2001-08-17 2003-02-27 Luminex Corporation Method for characterizing autoimmune disorders
US20050164261A1 (en) * 2001-10-09 2005-07-28 Chandler Don J. Multiplexed analysis of clinical specimens apparatus and methods
US8148171B2 (en) * 2001-10-09 2012-04-03 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
KR100524821B1 (ko) * 2002-10-28 2005-10-31 학교법인 서강대학교 보체 １ｑ를 이용한 단백질 칩 검출방법
CA2505125A1 (en) * 2002-11-08 2004-05-27 Sheldon P. Rothenberg Assay for autoantibodies to folate receptors
GB2424273B (en) * 2002-11-14 2007-06-27 Univ Nottingham Method for preparing tumour marker protein
US7335359B2 (en) 2003-02-06 2008-02-26 Tripep Ab Glycosylated specificity exchangers
EP1594898A2 (de) 2003-02-06 2005-11-16 Tripep AB Glycosylierte spezifitätaustauscher
GB2426581A (en) * 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
SI1889059T1 (sl) 2005-05-27 2009-12-31 Oncimmune Ltd Izboljšani imunotestni postopek
WO2007062359A1 (en) * 2005-11-21 2007-05-31 Oregon Health & Science University Methods and reagents for elimination or reduction of false positives in the analysis of a sample
CN101632020B (zh) 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
EP2097750A2 (de) * 2006-10-26 2009-09-09 Abbott Laboratories Immunoassay aus analyten in proben mit endogenen antikörpern gegen analyte
US7776605B2 (en) * 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
CN101657719A (zh) * 2007-01-26 2010-02-24 路易斯维尔大学研究基金会公司 检测用于诊断和表征障碍的自身抗体的方法
US20090092631A1 (en) * 2007-03-26 2009-04-09 Tripep Ab Glycosylated specificity exchangers that induce an antibody dependent cellular cytotoxicity (adcc) response
GB0725239D0 (en) * 2007-12-24 2008-02-06 Oncimmune Ltd Calibrator for autoantibody assay
US20100261292A1 (en) * 2009-04-10 2010-10-14 Meso Scale Technologies, Llc Methods for Conducting Assays
MY151976A (en) 2009-07-21 2014-07-31 Sekisui Medical Co Ltd Insulin assay
WO2013154709A1 (en) 2012-04-13 2013-10-17 Diabetomics, Llc Maternal biomarkers for gestational diabetes
CN110632290B (zh) * 2019-09-27 2022-04-12 昆山迪安医学检验实验室有限公司 一种抗双链dna抗体检测试剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3720760A (en) * 1968-09-06 1973-03-13 Pharmacia Ab Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples
US3654090A (en) * 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies
GB1508132A (en) * 1974-05-20 1978-04-19 Technicon Instr Analysis of biological fluids
US4024235A (en) * 1975-07-21 1977-05-17 Corning Glass Works Detection and quantitation of viral antibodies
US4020151A (en) * 1976-02-17 1977-04-26 International Diagnostic Technology, Inc. Method for quantitation of antigens or antibodies on a solid surface
US4134124A (en) * 1976-11-27 1979-01-09 Ferranti Limited Semiconductor devices and circuit arrangements including such devices
US4184849A (en) * 1977-12-05 1980-01-22 Technicon Instruments Corporation Mixed agglutination
GB2045431B (en) * 1979-02-26 1983-04-20 Technicon Instr Immunoassay utilising two particulate reagents
DE3264269D1 (en) * 1981-07-17 1985-07-25 Toray Industries Method of assaying biologically active substances and labelling agents therefor
US4687732A (en) * 1983-06-10 1987-08-18 Yale University Visualization polymers and their application to diagnostic medicine
NZ212546A (en) * 1984-07-16 1988-09-29 Abbott Lab Immunoassay for detecting antibody to hepatitis b surface antigen/a
US4855242A (en) * 1986-04-14 1989-08-08 Joslin Diabetes Center, Inc. Method of detecting antibodies
EP0353895A1 (de) * 1988-07-18 1990-02-07 MITSUI TOATSU CHEMICALS, Inc. Immunoassay-Methode
ES2077670T3 (es) * 1988-12-13 1995-12-01 Univ Florida Metodos y composiciones que sirven para la deteccion precoz y el tratamiento de la diabetes mellitus dependiente de la insulina.
CA2021946A1 (en) * 1989-07-28 1991-01-29 Mitsubishi Chemical Corporation Determination and detection of antibody and its immunoglobulin class
US6682906B1 (en) * 1990-09-21 2004-01-27 The Regents Of The University Of California Cloned glutamic acid decarboxylase
US5464749A (en) * 1991-07-22 1995-11-07 Bayer Corporation Immunoassay of free substances in biological fluids
US5200318A (en) * 1992-05-13 1993-04-06 Miles Inc. Diagnosis of IDDM with a panel of immunoreagents

Also Published As

Publication number Publication date
CA2200683A1 (en) 1996-03-28
EP0782710A1 (de) 1997-07-09
DE69516007D1 (de) 2000-05-04
ATE191277T1 (de) 2000-04-15
WO1996009552A1 (en) 1996-03-28
US5561049A (en) 1996-10-01
EP0782710B1 (de) 2000-03-29
JP3104999B2 (ja) 2000-10-30
JPH09511582A (ja) 1997-11-18
AU3632195A (en) 1996-04-09
AU695419B2 (en) 1998-08-13
ES2145924T3 (es) 2000-07-16

Similar Documents

Publication Publication Date Title
DE69516007T2 (de) Verfahren zum nachweiss von antikörpern
PT69900A (pt) Sol particle labelled immuno-assay
ATE99060T1 (de) Testverfahren und reagenzsatz dazu.
DE59003503D1 (de) Verfahren zum Nachweis spezifisch bindefähiger Substanzen in Körperflüssigkeiten.
ATE118275T1 (de) Immunoassayverfahren zum nachweis von antigenen.
DD130807A5 (de) Verfahren zur radioimmunologischen bestimmung der antigen-oder antikoerperkonzentration in proben und vorrichtung zur durchfuehrung des verfahrens
ATE15274T1 (de) Verfahren und ausruestung zum testen von antikoerpern gegen loesliche antigene.
ATE184108T1 (de) Mca prüfung/kit zum nachweis von metallkationen
ATE208900T1 (de) Verringerung des hook-effekts in immuntests mit teilchenförmigem trägermaterial
ATE120550T1 (de) Verfahren zum nachweis von malignen erkrankungen.
DE59107797D1 (de) Verfahren zum Nachweis von phosphoryliertes Tyrosin enthaltenden Proteinen
ATE397215T1 (de) Entstörung von immunoassays durch substanzen, die aus den framework-regionen von antikörpern abgeleitet sind
ES483606A1 (es) Metodo y su correspondiente kit de prueba para la deteccion-y-o determinacion de una inmunoglobulina especifica antige- nica.
SE9502024D0 (sv) Pathogen assay method
DE69942215D1 (de) Verfahren zum immunochemischen Testen des Anti-HM1.24-Antikörpers
ATE164682T1 (de) Verfahren zur immunchemischen bestimmung eines analyten
ATE121197T1 (de) Immunometrisches verfahren zum nachweis von lipoprotein-teilchen, anti-lp(a) monoklonale antikörper und ihre anwendung zur diagnose von atherosklerose.
ATE232981T1 (de) Differenziertes timingsverfahren zum nachweiss multiple analyte in eine testprobe
ATE188551T1 (de) Feststellung von antikörperproduktion
DE69930843D1 (de) Verfahren zum bestimmen von autoantikörpern
DE69928125D1 (de) EIN VERFAHREN ZUM AUFFINDEN UND/ODER QUANTIFIZIEREN EINES SPEZIFISCHEN IgE-ANTIKÖRPERS IN EINER FLÜSSIGEN PROBE
ATE111226T1 (de) Verfahren zum nachweis von analyten.
ATE191565T1 (de) Verfahren zum nachweisen von antikörpern und antigenen
DE50008417D1 (de) Verfahren zur bestimmung der avidität von antikörpern
DE58902996D1 (de) Verfahren zum nachweis von antikoerpern gegen erythrozytenspezifische antigene.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition